1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Panic Disorders Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Panic Disorders Clinical Trials by Region
2.2.2 Average Enrollment of Panic Disorders Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Panic Disorders Treatment, 2019

3. Region wise Panic Disorders Clinical Trials
3.1 Asia Pacific Panic Disorders Clinical Trials by Country
3.2 Europe Panic Disorders Clinical Trials by Country
3.3 North America Panic Disorders Clinical Trials by Country
3.4 Middle East and Africa Panic Disorders Clinical Trials by Country
3.5 South and Central America Panic Disorders Clinical Trials by Country

4. Panic Disorders Clinical Trial Trends
4.1 Start Year wise Panic Disorders Clinical Trials
4.2 Phase wise Panic Disorders Clinical Trials
4.3 Trial Status wise Panic Disorders Clinical Trials
4.4 Trial Type wise Panic Disorders Clinical Trials

5. Panic Disorders Average Enrollment Trends
5.1 Average Enrollment in Panic Disorders Trials by Year
5.2 Average Enrollment in Panic Disorders Trials by Phase
5.3 Average Enrollment in Panic Disorders Trials by Status
5.4 Average Enrollment in Panic Disorders Trials by Type of Trial

6. Companies Participating in Panic Disorders Clinical Trials
6.1 Panic Disorders Trials by Sponsor Type
6.2 Panic Disorders Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Panic Disorders Trials- Phase 1
7.2 Panic Disorders Trials- Phase 2
7.3 Panic Disorders Trials- Phase 3
7.4 Panic Disorders Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Panic Disorders Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Panic Disorders Clinical Trials and Enrolment
Figure 5: Europe - Country wise Panic Disorders Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Panic Disorders Clinical Trials and Enrolment
Figure 7: North America - Country wise Panic Disorders Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Panic Disorders Clinical Trials and Enrolment
Figure 9: Panic Disorders Clinical Trials by Phase
Figure 10: Panic Disorders Clinical Trials by Trial Status
Figure 11: Panic Disorders Clinical Trials by Type
Figure 12: Panic Disorders Clinical Trials by Sponsor Type
Figure 13: Panic Disorders Clinical Trials by Leading Sponsors
Figure 14: Panic Disorders Average Enrollment by Phase
Figure 15: Panic Disorders Average Enrollment by Trial Status
Figure 16: Panic Disorders Average Enrollment by Type
Figure 17: Panic Disorders- Average Enrolment by Type of Sponsors
Figure 18: Panic Disorders- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Panic Disorders Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Panic Disorders Clinical Trials and Enrolment
Table 5: Europe - Country wise Panic Disorders Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Panic Disorders Clinical Trials and Enrolment
Table 7: North America - Country wise Panic Disorders Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Panic Disorders Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Panic Disorders Average Enrollment by Phase
Table 15: Panic Disorders Average Enrollment by Trial Status
Table 16: Panic Disorders Average Enrollment by Type
Table 17: Panic Disorders- Average Enrolment by Type of Sponsors
Table 18: Panic Disorders- Enrolment by Leading Sponsors

Companies mentioned
Allergan Plc, Dexcel PT Holdings Ltd, Eli Lilly and Co, GlaxoSmithKline Plc, Mylan NV, Pfizer Inc, PRACS Institute, Ltd., Syneos Health Inc, The Lundbeck Foundation, Torrent Pharmaceuticals Ltd